Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion type Assertion NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_head.
- NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion description "[To determine whether CCL2 mRNA expression is beneficial or detrimental for cervical cancer patients, the association between the expression of this molecule by cervical tumour cells, the number of tumour-associated macrophages, and clinicopathological parameters such as recurrence, relapse-free survival, and overall patient survival was investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_provenance.
- NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion evidence source_evidence_literature NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_provenance.
- NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion SIO_000772 16435282 NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_provenance.
- NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion wasDerivedFrom befree-20140225 NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_provenance.
- NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_assertion wasGeneratedBy ECO_0000203 NP722300.RAP54Ky64PPCp9Ck-TeYnJIyRt_a20DnQyeOKwkHK_dfg130_provenance.